Advertisement
SII is currently manufacturing anti-coronavirus vaccine Covishield, developed by Astrazeneca and Oxford University. The vaccine is not only being used in India, but exported to a number of countries.
Poonawalla had earlier admitted that SII has been facing problems in sending out required number of batches of vaccines due to the bureaucratic and government-related hurdles.
Tagging the twitter handle of the President of the United States, Poonawalla said in a tweet, “Respected @POTUS, if we are to truly unite in beating this virus, on behalf of the vaccine industry outside the U.S., I humbly request you to lift the embargo of raw material exports out of the U.S. so that vaccine production can ramp up. Your administration has the details.”